In March of this year, the AAP
released a statement saying that once again pediatricians can use either
flu shots or nasal spray flu vaccines for their patients. This guidance applies
to the 2020-21 flu season, and is the same recommendation issued for the
2019-20 season. The AAP and CDC did not recommend using the nasal spray in
2016-17 or 2017-18 due to poor effectiveness against H1N1 strains. LAIV
manufacturer AstraZeneca has since changed the formulation of the vaccine.
According to a report
issued by the CDC in April, 166 children died during the 2019-20 flu
season. The CDC estimates about 39 million people have gotten sick with flu,
410,000 have been hospitalized and 24,000 have died this season. Hospitalization
rates for children remain unusually high. Children ages 4 and under have been
hospitalized at a rate of 94.1 per 100,000 children, the highest the CDC has on
record for this age group. Last season’s vaccine was 55% effective for children
and teens according
to the CDC.
Flu vaccine efficacy varies from year to year depending on
the similarity of the flu viruses the vaccine is designed to prevent and the
flu viruses in the community. However, recent studies show that have supported
the conclusion that flu vaccination benefits public health. The CDC recommends
that everyone age 6 months and older receive a flu vaccine yearly by the end of
October. Benefits of vaccination
contracting the flu. In seasons where the vaccine is well matched, it
reduces the risk of having to visit the doctor with flu by 40
percent to 60 percent.
the severity of flu if contracted. A 2018 study showed that among adults
hospitalized with flu vaccinated patients were 59 percent less likely to be admitted
to the ICU.
Quadrivalent Influenza Vaccine is an injectable immunization approved for
patients 6 months and up. Fluzone is an inactivated vaccine protecting against
four strains of the flu. In addition, Fluzone is approved for pregnant women.
Another option for flu is FluMist Quadrivalent, which is
a nasal-spray flu vaccine approved for ages 2 through 49. FluMist is a live
attenuated influenza vaccine and is not for use in pregnant women.
For some, the flu is a mild illness. For older adults,
especially those with chronic health conditions such as diabetes or heart
disease, the flu can be far more serious. Older adults are at high-risk to
complications from the flu such as pneumonia. It’s estimated that
between 70 and 90 percent of flu related dates occurred in people over 65, and
between 50 and 70 percent of seasonal-flu related hospitalizations occur in
that age group. Adults age 50 to 64 can choose from any available flu vaccine.
For adults 65 and older, the CDC recommends one of two vaccines developed specifically
for that age group: the high dose flu
vaccine and the adjuvanted flu
The high dose vaccine, Fluzone
High Dose, delivers 4X the amount of antigen as the regular dose Fluzone
vaccine. Compared to Fluzone, Fluzone High dose provides between 24%1 and
51%2 better protection from influenza.
The adjuvanted vaccine, Flublok
Quadrivalent, is approved for persons ages 18 and older. Flublok has 3X the
HA of a standard-dose quadrivalent inactivated influenza vaccine. Flublock also
prevents more cases of flu in adults 50+ than a standard-dose quadrivalent
vaccine. People over 65 should talk to their doctor about the pneumococcal vaccination,
which can help prevent pneumococcal pneumonia,
a serious flu-related complication.
Earlier this month, the AAP released their updated recommendations
for the use of influenza vaccines and antiviral medications in children. These
include no preference for the inactivated or live attenuated vaccine, updated
guidelines for children receiving their first flu vaccine, and information
about a new antiviral medication. The recommendations can be viewed
1 24.2% Primary endpoint: the occurrence of laboratory-confirmed,
protocol-defined, influenza-like illness caused by viral strains regardless of
their antigenic similarity to vaccine components.
2 51.1% Secondary endpoint: the occurrence of
culture-confirmed influenza caused by viral types/subtypes antigenically
similar to those contained in the respective annual vaccine formulations in
association with a modified Centers for Disease Control and Prevention-defined
Sanofi Pasteur has put together a wealth of coding resources
for the 2019-2020 flu season. Coding and billing for vaccinations can be
complicated, so these resources are designed to save your practice time.
Sanofi has scheduled two webinars to assist in flu coding.
One is targeted at coding for patients of any age, and the other is
specifically for pediatric patients. The all ages webinar is scheduled for
August 20 and September 12, 18, and 19. The pediatric webinar is scheduled for
August 21 and September 10. The webinar will cover essential coding and billing
information, Medicaid billing and VFC, Medicare billing, and payment
The second guide, 2019-2020
Proper Codes of Sanofi Pasteur Products, includes product codes, NDCs in
billing format, IDC-10 codes, administration codes, and CVX codes for each
vaccine. It has been updated to include this year’s flu vaccinations.
CPP is pleased to announce two programs our member practices can utilize to access flu vaccine discounts and benefits for the upcoming 2015-2016 flu season:
Sanofi Pasteur – The pre-book period is now open so book your flu reservation by going to www.VaccineShoppe.com
• If your practice purchased Fluzone® last season (2014-2015), Sanofi Pasteur has allocated to you the total doses of each flu presentation that shipped to your practice.
• This allocation can be adjusted up or down, depending on your practice’s anticipated need for the upcoming season (2015-2016), however you must confirm your reservation by March 31, 2015.
• Because prefilled syringes are in higher demand, it is recommended that you confirm your reservation for this type of presentation by the end of February 2015.
MedImmune – CPP member practices can receive 5% off all orders of FluMist® throughout the entire 2015-2016 flu season, whether the doses are part of a pre-book or a part of subsequent reorders.
• For CPP members that submitted the MedImmune Declaration Form last flu season you can place your FluMist® order with your distributor right now. You do not need to submit a new declaration form in 2015.
• For CPP members who want access to the CPP – MedImmune contract discount, please contact the CPP office at 614-722-2149 or email email@example.com to obtain a copy of the declaration form.
FluMist® doses must be pre-booked by April 17, 2015.
For pricing information and additional information, please contact CPP at 614-722-2149 or firstname.lastname@example.org.